Handelsbanken Fonder AB Makes New Investment in Astera Labs, Inc. $ALAB

Handelsbanken Fonder AB bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm bought 32,400 shares of the company’s stock, valued at approximately $2,930,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Alliancebernstein L.P. raised its position in Astera Labs by 114.2% in the 1st quarter. Alliancebernstein L.P. now owns 8,401,019 shares of the company’s stock valued at $501,289,000 after buying an additional 4,478,741 shares during the last quarter. Atreides Management LP increased its holdings in shares of Astera Labs by 153.3% during the 1st quarter. Atreides Management LP now owns 4,652,264 shares of the company’s stock worth $277,601,000 after acquiring an additional 2,815,614 shares during the last quarter. Vanguard Group Inc. raised its position in shares of Astera Labs by 29.6% in the second quarter. Vanguard Group Inc. now owns 12,049,223 shares of the company’s stock valued at $1,089,491,000 after purchasing an additional 2,751,747 shares during the period. FengHe Fund Management Pte. Ltd. bought a new position in Astera Labs in the 2nd quarter valued at about $106,772,000. Finally, Bank of Nova Scotia increased its stake in shares of Astera Labs by 3,742.2% during the first quarter. Bank of Nova Scotia now owns 964,400 shares of the company’s stock worth $57,546,000 after purchasing an additional 939,300 shares during the period. Institutional investors and hedge funds own 60.47% of the company’s stock.

Analysts Set New Price Targets

ALAB has been the subject of several analyst reports. Needham & Company LLC lifted their price objective on shares of Astera Labs from $205.00 to $220.00 and gave the stock a “buy” rating in a research note on Wednesday, November 5th. Barclays reiterated an “equal weight” rating and issued a $155.00 price target on shares of Astera Labs in a research report on Monday, October 20th. JPMorgan Chase & Co. increased their target price on shares of Astera Labs from $180.00 to $215.00 and gave the company an “overweight” rating in a research report on Wednesday, November 5th. Cowen restated a “hold” rating on shares of Astera Labs in a report on Wednesday, November 5th. Finally, Citigroup boosted their target price on shares of Astera Labs from $160.00 to $275.00 and gave the company a “buy” rating in a report on Wednesday, September 17th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and eight have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $187.06.

Insider Transactions at Astera Labs

In other Astera Labs news, COO Sanjay Gajendra sold 90,459 shares of Astera Labs stock in a transaction dated Monday, November 17th. The shares were sold at an average price of $144.69, for a total value of $13,088,512.71. Following the sale, the chief operating officer owned 1,599,750 shares of the company’s stock, valued at approximately $231,467,827.50. The trade was a 5.35% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Manuel Alba sold 183,000 shares of the firm’s stock in a transaction on Tuesday, September 2nd. The stock was sold at an average price of $173.27, for a total value of $31,708,410.00. Following the completion of the sale, the director directly owned 385,863 shares of the company’s stock, valued at $66,858,482.01. This represents a 32.17% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 596,936 shares of company stock worth $92,515,610. 12.50% of the stock is owned by insiders.

Astera Labs Trading Down 2.0%

Astera Labs stock opened at $144.78 on Wednesday. The firm has a market capitalization of $24.45 billion, a price-to-earnings ratio of 130.43, a price-to-earnings-growth ratio of 2.76 and a beta of 1.37. Astera Labs, Inc. has a 1-year low of $47.13 and a 1-year high of $262.90. The firm’s fifty day moving average price is $181.56 and its two-hundred day moving average price is $147.85.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, November 4th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of $0.39 by $0.10. The firm had revenue of $230.58 million during the quarter, compared to the consensus estimate of $206.42 million. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.During the same period in the prior year, the business posted $0.23 earnings per share. The company’s quarterly revenue was up 103.9% compared to the same quarter last year. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, research analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current year.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.